current page:home>Markets in Detail>Options>Article

Study: ImClone Drug Improves Survival

This Site:en.yinlu.net Source:en.yinlu.net Writer: Time:2007-11-16

NEW YORK (AP) -- ImClone Systems Inc. said Wednesday data from a study showed its Erbitux cancer drug improves survival rates in advanced colorectal cancer cases when used alone.

ImClone developed Erbitux and markets it with Bristol-Myers Squibb Co. The drug was approved in October by the U.S. Food and Drug Administration to treat colorectal cancer.

The Phase III clinical trial compared survival rates in patients with metastatic colorectal cancer when treated with Erbitux versus chemotherapy. It was conducted by the National Cancer Institute of Canada Clinical Trials Group and the results were published in the New England Journal of Medicine.

"These data demonstrate that ERBITUX may provide certain colorectal cancer patients with additional time even when other available treatment options have failed," Bristol-Myers' oncology director, Dr. Maurizio Voi, said in a statement.

ImClone shares added 20 cents to $44.22 in electronic aftermarket trading, after closing Wednesday at $44.02.

上一篇：Investment Adviser Charged in Ponzi Scam 下一篇：Web Conglomerate to Break Off Units

[

Collection] [

Commend] [

Comment On(0Item)] [Back Top] [Print] [Close]

Hot Article

·Scotts Miracle-Gro CEO Exercis
·L-3 Communications SVP Exercis
·DaVita Chairman Exercises Opti
·VeriSign Executive VP Exercise
·Digital River Director Exercis
·Haynes Controller Exercises Op
·IBM Senior VP Exercises Option
·DRS Technologies Wins Navy Con
·Cytyc Corp. Senior VP Exercise
·Nordstrom Executive VP Exercis
·Thermo Fisher CFO Exercises Op
·Thermo Fisher SVP Exercises Op
·Parker Hannifin CFO Exercises
·CheckFree Executive VP Sells S
·AmeriCredit Amends Some Direct
·ICO CFO Exercises Options
·Cytyc CFO Exercises Options
·Review: Amazon Didn't Crack My
·Ind. Coal Plant Foes Gird Them
·Weak Home Sales Affect Retirem

Correlation Article

·Investment Adviser Charged in
·Web Conglomerate to Break Off
·Fla. Deal to Expand Tribal Gam
·Alaska Senators Differ With Go
·Diabetes Drug to Warn of Risk
·Forest Oil SVP Exercises Optio
·Forest Oil CEO Exercises Optio
·Sangamo BioSciences VP Exercis
·Blackbaud CFO Exercises Option
·Blackbaud CEO Exercises Option
·Precision Castparts CFO Sells
·FTD Group CEO Sells 18,500 Sha
·First Solar CFO Exercises Opti
·Sterling Bancshares CEO Sells
·ProLogis COO Exercises Options
·Phase Forward SVP Exercises Op
·Amazon.com Senior Vp Exercises
·Harris Financial Chief Exercis
·Oil Prices Drop More Than US$1
·Interwoven to Restate Results